OLEG NODELMAN

CIK 1454385 · last filed 2026-01-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.03B

Companies

5

Total Filings

18

Lifetime Open-Market Net

$177.46M

Filer Profile

Reported Address
357 TEHAMA STREET #3
SAN FRANCISCO, CA 94103
Related Filers
EcoR1 Capital, LLC — 28 joint filings, latest 2026-01-12
EcoR1 Capital Fund Qualified, L.P. — 12 joint filings, latest 2023-09-22
Biotech Opportunity GP, LLC — 10 joint filings, latest 2023-09-22
EcoR1 Venture Opportunity Fund, LP — 10 joint filings, latest 2023-09-22
ANAPTYSBIO, INC — 5 joint filings, latest 2025-01-02
EcoR1 Panacea Holdings, LLC — 4 joint filings, latest 2021-04-13
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AKTS Director 347,305 $23.94 $8.31M $80.00M 1 2026-01-12
ZYME Director 22,970,388 $26.43 $607.22M $52.14M 9 2025-06-27
Nuvation Bio Inc. (NUVB.WS) Delisted Director 12,504,675 $0.01 $63.8K $40.15M 2 2023-09-22
ANAB Director 7,521,024 $55.16 $414.86M $0 1 2022-05-09
Kindred Biosciences, Inc. (KIN) Delisted Director 540,936 $9.25 $5.00M $5.16M 5 2014-09-30

Recent Filings · Page 2 of 2

18 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-09-22 Nuvation Bio Inc. (NUVB.WS) Delisted Buy (P) +31,878,600 $40.15M EDGAR
2022-05-09 ANAB Mixed $0 EDGAR
2021-11-02 Nuvation Bio Inc. (NUVB.WS) Delisted Grant (A) $0 EDGAR
2014-09-30 Kindred Biosciences, Inc. (KIN) Delisted Buy (P) +100,000 $956.0K EDGAR
2014-08-29 Kindred Biosciences, Inc. (KIN) Delisted Buy (P) +47,000 $509.9K EDGAR
2014-08-27 Kindred Biosciences, Inc. (KIN) Delisted Buy (P) +85,244 $895.1K EDGAR
2014-02-05 Kindred Biosciences, Inc. (KIN) Delisted Grant (A) $0 EDGAR
2013-12-13 Kindred Biosciences, Inc. (KIN) Delisted Mixed +400,000 $2.80M EDGAR
Showing 1118 of 18
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.